Detalles de la búsqueda
1.
Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.
J Clin Oncol
; 34(13): 1500-9, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926681
Resultados
1 -
1
de 1
1
Próxima >
>>